citric acid, anhydrous has been researched along with Inflammatory Response Syndrome, Systemic in 1 studies
Citric Acid: A key intermediate in metabolism. It is an acid compound found in citrus fruits. The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability.
citric acid : A tricarboxylic acid that is propane-1,2,3-tricarboxylic acid bearing a hydroxy substituent at position 2. It is an important metabolite in the pathway of all aerobic organisms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Humes, HD | 1 |
| Sobota, JT | 1 |
| Ding, F | 1 |
| Song, JH | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Novel Extracorporeal Treatment to Modulate Hyperinflammation in COVID-19 Patients[NCT04353674] | 40 participants (Anticipated) | Interventional | 2020-04-28 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for citric acid, anhydrous and Inflammatory Response Syndrome, Systemic
| Article | Year |
|---|---|
A selective cytopheretic inhibitory device to treat the immunological dysregulation of acute and chronic renal failure.
Topics: Acute Kidney Injury; Anticoagulants; Antigen-Presenting Cells; Atherosclerosis; Cardiovascular Disea | 2010 |